UT Southwestern Medical Center at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

UT Southwestern Medical Center brings 35 presentations to ObesityWeek 2026 in National Harbor. Its program centers on obesity medicines, from trials of new GLP-1 drugs such as aleniglipron, retatrutide and berobenatide to real-world studies of GLP-1 use, coverage loss and pregnancy outcomes. It also shows how fasting and exercise drive ghrelin release through sympathetic nerve circuits.

OrganizationObesityWeek 2026 Attendance
Universities & research institutes
Academic medical center in Dallas with a medical school, research labs and hospitals.
Session
Fri Nov 13
1:00pm–6:15pm
Pediatric Obesity: Comprehensive Care and Practical Strategies for Today's Clinician - Day 1
Practical course for clinicians on pediatric obesity care, combining nutrition, behavior therapy and newer drugs, with case simulations and workflow strategies.
with Wake Forest University, University of Minnesota, Obesity Action Coalition
Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food
Talk
Fri Nov 13
2:00pm–2:45pm
Medical Assessment of Obesity
Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food
Talk
Sat Nov 14
11:15am–11:30am
Metabolic Responses to Exercise and Fasting Depend on Sympathetic-Driven Ghrelin Secretion
Metabolism and Integrative Physiology · Neuroscience · Pharmacology · Chronic Disease · Nutrition · Bariatric Surgery and Devices
Talk
Sat Nov 14
2:00pm–2:15pm
GLP-1 Agonists and Risk of Falls and Wheelchair Use in Older Adults
Metabolism and Integrative Physiology · Neuroscience · Pharmacology · Chronic Disease
Talk
Sat Nov 14
6:25pm–6:35pm
Award for Distinguished Mentorship Recipient
Metabolism and integrative physiologyNeuroscience of appetite and eatingInterventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practicePolicy and public health
Poster
Sat Nov 14
7:30pm–8:30pm
Poster
Sat Nov 14
7:30pm–8:30pm
STEP UP of Semaglutide 7.2 mg from 2.4 mg in Obesity: Predicted Benefit and Clinical Confirmation
Chronic disease and obesity complicationsObesity pharmacotherapy and drug development
Poster
Sat Nov 14
7:30pm–8:30pm
Talk
Sun Nov 15
7:30am–8:30am
The Obesity Treatment Journey: Evaluating Burden, Discontinuation, and Outcomes
Uses a patient case and real-world data to examine why patients stop obesity treatment, what follows, and care changes that keep people on therapy.
Talk hosted by Amgen
Riverview Ballroom B
with knownwell
Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practicePolicy and public healthNutrition, diet and foodChronic disease and obesity complicationsNeuroscience of appetite and eatingObesity pharmacotherapy and drug development
Session
Sun Nov 15
9:30am–10:30am
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Sun Nov 15
2:30pm–3:30pm
Session
Sun Nov 15
3:30pm–4:30pm
Eloralintide Phase 2 Clinical Outcomes Oral Session
Interventional and Clinical Studies · Chronic Disease
Talk
Sun Nov 15
4:20pm–4:30pm
Commentary
Interventional and Clinical Studies · Chronic Disease
Talk
Sun Nov 15
5:00pm–6:30pm
The TRIUMPH Program: Anthropometric and Cardiometabolic Risk Factor Improvements with Retatrutide
Woodrow Wilson, Ballroom Level
Interventional and Clinical Studies · Pediatrics · Chronic Disease
Talk
Sun Nov 15
5:20pm–5:25pm
Lipid Mobilization Establishes Metabolic Tolerance to Infection
Metabolism and integrative physiologyInterventional and clinical studiesClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentChronic disease and obesity complicationsNutrition, diet and food
Talk
Sun Nov 15
6:30pm–9:00pm
Obesity in Focus: Today's Evidence. Tomorrow's Possibilities.
Speakers cover what has changed in obesity guidelines, evidence behind approved obesity drugs, and the biology of amylin and new amylin analog data.
Talk hosted by Novo Nordisk
with UTHealth Houston, University of Zurich, Washington Center for Weight Management & Research +1 more
Interventional and clinical studiesClinical obesity care and professional practiceNutrition, diet and foodObesity pharmacotherapy and drug development
Talk
Mon Nov 16
11:45am–12:45pm
Glucagon’s Role in Metabolic Regulation and Why It Matters
Covers how glucagon and the liver regulate glucose and fat metabolism and why this matters in obesity and related heart, kidney and metabolic diseases.
Talk hosted by Boehringer Ingelheim
Riverview Ballroom B
with Wake Forest University, Weill Cornell Medicine, PAs in Obesity Medicine +1 more
Metabolism and integrative physiologyChronic disease and obesity complications
Session
Mon Nov 16
12:00pm–1:00pm
TOS Population Science and Public Health Section Meeting (TOS members only)
Section members hear talks from early-career top abstract award winners, get section updates and learn about open leadership positions.
with University of Pennsylvania, Kaiser Permanente, Emory University +2 more
Population health and epidemiologyPolicy and public health
Poster
Mon Nov 16
2:30pm–3:30pm
Poster
Mon Nov 16
2:30pm–3:30pm
Poster
Mon Nov 16
2:30pm–3:30pm
Poster
Mon Nov 16
2:30pm–3:30pm
Poster
Mon Nov 16
2:30pm–3:30pm
Session
Tue Nov 17
11:00am–12:30pm
Brainy Brunch Trivia Throwdown
Closing brunch where tables team up for trivia drawn from across the meeting, mixing attendees from different tracks to swap takeaways.
Riverview Ballroom
with Vanderbilt University

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UT Southwestern Medical Center

Tell us what you sell and we’ll find the people at UT Southwestern Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction